Israel’s Fertilizer Industry Prevails Amid Conflict

In the wake of the third quarter financial results for 2023, Israel Chemicals Ltd (ICL) has affirmed its operational resilience amidst the ongoing Israel and Hamas military conflict. The company reported uninterrupted operations even after the significant attack on Israel on October 7, 2023. ICL’s President and CEO, Raviv Zoller, emphasized the company’s unwavering commitment to customers, strategic growth, and the well-being of employees and local communities.

The financial results for the quarter ending September 30, 2023, revealed a decline in consolidated sales to $1.9 billion from the previous year’s $2.5 billion. Operating income also saw a decrease, standing at $227 million compared to last year’s $935 million. However, operating cash flow remained robust at $407 million, and adjusted EBITDA was reported at $346 million.

Raviv Zoller commented on the resilience of ICL amidst challenging market conditions, citing strong cash generation and ongoing efficiency initiatives. He acknowledged competitive pressures in certain sectors but remained optimistic about the recovery in demand for specialty businesses and a stable growth trajectory in 2024.

The third quarter also saw varied performance in different segments of ICL’s portfolio. Potash revenues were $526 million, a decrease from $854 million in the previous year. Phosphate specialties and phosphate commodities also experienced declines in sales.

ICL Group continues to be a major player in the global market, offering solutions in food, agriculture, and industrial sectors aimed at addressing sustainability challenges. Despite the geopolitical turmoil, the company’s steady operation and strategic focus highlight its resilience and commitment to growth amidst adversity.

Add Fertilizer Daily to your followed sources to get market news first  

Enjoyed the story?

Once a week, our subscribers get their hands first on hottest fertilizer and agriculture news. Don’t miss it!

SEE THE EXAMPLE

GET THE NEWSLETTER!